Blog Archives

Abilify MyCite, the first digital pill. Where does all that silicone go?

November 16, 2017 – The American Food & Drug Administration (FDA) just approved Ability MyCite,  a pill with a sensor that digitally tracks if patients have ingested their medication. This is a very first in its class at the new age of digital health.

Read more ›

Tags: , , , , , , , , , ,

DRESS: Rare but serious skin reaction with Zyprexa (Olanzapine)

May 11, 2016 – We do learn from a very recent Drug Safety Communication (DSC) by the American Food & Drug Administration (FDA) that olanzapine, the pharmacologically active component in Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, Symbyax,

Read more ›

Tags: , , , , , , , , ,

Cariprazine (Vraylar): New treatment for schizophrenia and bipolar disorder approved

 September 19, 2015 – The American Food and Drug Administration (FDA) just approved Cariprazine (Vraylar) capsules to treat schizophrenia and bipolar disorder in adults.

Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, symptoms are first seen in adults younger than 30 years of age and include hearing voices or seeing things that are not there,

Read more ›

Tags: , , , , ,

Brexpiprazole (Rexulti): A new drug to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder approved by the FDA

July 19, 2015 – Very recently, the U.S. Food and Drug Administration (FDA) approved Brexpiprazole (Rexulti) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).

Read more ›

Tags: , , ,

Drug Safety Communication: Asenapine Maleate [Saphris] Associated with Serious Allergic Reactions

September 01, 2011 – Asenapine Maleate [Saphris] is used to treat symptoms of schizophrenia and bipolar disorder. The American Food and Drug Administration (FDA) has notified healthcare professionals and patients that serious allergic reactions have been reported with the use of Asenapine Maleate [Saphris]. The Contraindications,

Read more ›

Tags: , , ,

thasso: community

thasso: conditions

thasso post: magazine

View my Flipboard Magazine.

thasso: follow us

thasso: chat

You must be a registered user to participate in this chat.

thasso: tweets

thasso: categories

thasso: archives

More Feeds

Top